Get the App

Back Stocks profile

Stock analysis tool for investors

Zenith Drugs Ltd.

NSE: ZENITHDRUG | BSE:

₹78.15 2.90 (3.85%) 1D

Pharmaceuticals & Biotechnology

Buy Sell

Open an Account with Bigul in 5 minutes

Performance

Today’s low

75.50

Today’s High

79.00

52W low

52.80

52W High

114.50

Open Price

75.80

Prev. Close

66.8500

Volume

99200.00

Value

7752480.00

Fundamentals

Market Cap Cr

134.00

Price to Earnings

0.00

Price to Book Value

7.80

Dividend Yield

0.00

PE to Growth

0.00

Op Revenue TTM Cr

0.00

Net Profit TTM Cr

0.00

Cash From Operating Activity Cr

-4.41

Return on Equity %

29.88

EMA & SMA

Bullish Moving Averages

11

Bearish Moving Averages

0

5Day EMA

70.9

10Day EMA

67.5

12Day EMA

66.8

20Day EMA

66.1

26Day EMA

66.5

50Day EMA

70.4

EMA

EMA

5Day SMA

68.6

10Day SMA

65.2

20Day SMA

64.4

30Day SMA

64.4

50Day SMA

67.8

SMA

SMA

SMA

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

18 May, 2024

83.9

Week

81.1

Month

75

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

77.55

PIVOT

First Resistance

79.60

Second Resistance

81.05

Third Resistance

83.10

First Support

76.10

Second Support

74.05

Third Support

72.60

Relative Strength Index

69.33

Money Flow Index

73.96

MACD

0.31

MACD Signal

-1.88

Average True Range

3.87

Average Directional Index

35.55

Rate of Change (21)

24.24

Rate of Change (125)

Commodity Channel Index

390.1

Williams %R

-4.3

BETA

1 Month

1.36

3 Month

1 Year

3 Year

PRICE CHANGE ANALYSIS

↑ 27.38%

1 Week

Low

High

59.3

79

↑ 24.74%

1 Month

Low

High

59.3

79

↓ -1.08%

3 Months

Low

High

52.8

114.5

↓ -1.08%

6 Months

Low

High

52.8

114.5

↓ -1.08%

1 Year

Low

High

52.8

114.5

Indicator Graph
Total Qtr Revenue cr
Operating Expenses Qtr
Operating Profit Qtr
EBIDT Qtr Cr
Depreciation Qtr
Net Profit Qtr
Basic EPS Qtr
Indicator Mar 2022 Mar 2021 Mar 2020 Mar 2019 Graph
Total Revenue Annual 92.60 73.52 78.33 52.19
Operating Expenses Annual Cr 84.73 66.20 71.23 48.86
Operating Profit Annual 6.92 7.20 7.05 3.31
Operating Profit Margin Annual % 7.48 9.79 8.99 6.34
Total Expenses Annual Cr 88.20 68.92 73.46 50.61
EBIDT Annual Cr 7.87 7.31 7.11 3.33
EBIDT Annual margin % 8.50 9.95 9.07 6.38
Depreciation 1.34 1.22 0.92 0.81
PAT Before ExtraOrdinary Items Annual Cr 3.21 3.07 3.40 1.13
Net Profit Annual 3.21 3.07 3.40 1.13
Basic EPS Annual 80.32 76.66 85.00 28.35
Indicator Mar 2022 Mar 2021 Mar 2020 Mar 2019 Graph
Total ShareHolders Funds Annual 12.85 9.64 6.57 3.17
Minority Interest Liability Annual Cr - - - -
Total Non Current Liabilities Annual Cr 7.81 7.55 9.73 7.54
Total Current Liabilities Annual Cr 45.53 29.35 27.42 20.32
Total Capital Plus Liabilities Annual Cr 66.18 46.54 43.72 31.03
Fixed Assets Annual 10.45 9.21 9.01 4.99
Total Non Current Assets Annual 12.40 10.69 9.01 5.00
Total Current Assets Annual 53.79 35.85 34.72 26.03
Total Assets Annual 66.18 46.54 43.72 31.03
Contingent Liabilities plus Commitments Annual Cr 0.00 0.00 0.00 0.00
Indicator Mar 2022 Mar 2021 Mar 2020 Mar 2019 Graph
Cash from Operating Activity Annual 4.91 -0.89 3.48 -1.62
Cash from Investing Activity Annual 2.61 -1.43 -4.93 -0.43
Cash from Financing Annual Activity -0.83 2.88 1.36 2.46
Net Cash Flow Annual 6.69 0.57 -0.09 0.41
Indicator Mar 2022 Mar 2021 Mar 2020 Mar 2019 Graph
Book Value Per Share Annual 321.27 240.95 164.29 79.29
ROE Annual % 25.00 31.81 51.73 35.76
ROCE Annual % 31.63 35.43 37.96 23.58
Total Debt to Total Equity Annual 1.31 1.61 1.84 2.96
EBDIT Annual Margin % 8.58 9.96 9.08 6.38
Indicator Graph
Total Qtr Revenue cr
Operating Expenses Qtr
Operating Profit Qtr
EBIDT Qtr Cr
Depreciation Qtr
Net Profit Qtr
Basic EPS Qtr
Indicator Mar 2022 Mar 2021 Graph
Total Revenue Annual 92.67 73.52
Operating Expenses Annual Cr 84.82 66.37
Operating Profit Annual 6.83 7.03
Operating Profit Margin Annual % 7.37 9.56
Total Expenses Annual Cr 88.26 68.91
EBIDT Annual Cr 7.84 7.14
EBIDT Annual margin % 8.46 9.72
Depreciation 1.33 1.22
PAT Before ExtraOrdinary Items Annual Cr 3.13 3.03
Net Profit Annual 3.14 3.03
Basic EPS Annual 78.22 75.73
Indicator Mar 2022 Mar 2021 Graph
Total ShareHolders Funds Annual 12.09 8.95
Minority Interest Liability Annual Cr 0.01 0.00
Total Non Current Liabilities Annual Cr 9.90 7.62
Total Current Liabilities Annual Cr 46.58 29.97
Total Capital Plus Liabilities Annual Cr 68.58 46.55
Fixed Assets Annual 13.13 9.22
Total Non Current Assets Annual 15.05 10.70
Total Current Assets Annual 53.53 35.85
Total Assets Annual 68.58 46.55
Contingent Liabilities plus Commitments Annual Cr 0.00 0.00
Indicator Mar 2022 Mar 2021 Graph
Cash from Operating Activity Annual 5.15 0.76
Cash from Investing Activity Annual -5.24 -1.43
Cash from Financing Annual Activity 1.24 2.08
Net Cash Flow Annual 1.15 1.41
Indicator Mar 2022 Mar 2021 Graph
Book Value Per Share Annual 302.64 223.82
ROE Annual % 25.95 33.83
ROCE Annual % 29.60 35.75
Total Debt to Total Equity Annual 1.56 1.73
EBDIT Annual Margin % 8.55 9.73
Name Holding Percent Holding Id Pledged % Locked %
Name Holding Percent Holding Id Pledged % Locked %
AJAY SINGH DASSUNDI 22.52 75290256 0 100
SANDEEP BHARDWAJ 21.38 75290257 0 100
BHUPESH SONI 20.18 75290260 0 100
JAYWANTI SONI 2.94 75290262 0 100
PRIYANKA BHARADWAJ 1.94 75290259 0 100
ANJALI DASSUNDI 0.8 75290258 0 100
Name Holding Percent Holding Id
MERU INVESTMENT FUND PCC-CELL 1 2.2 75290268
ARIES OPPORTUNITIES FUND LIMITED 1.47 75290267
VIKASA INDIA EIF I FUND - ZODIAC GLOBAL OPPORTUNITY FUND 1.23 75290269
NEOMILE GROWTH FUND - SERIES I 1.11 75290265
Name Holding Percent Holding Id
PRAVEEN MUDUNURI 1.11 75290273
GRETEX SHARE BROKING LIMITED 3.47 75290276
YUGA STOCKS AND COMMODITIES PRIVATE LIMITED 1.17 75290277
Ex-Date Dividend Amount Dividend Type Record Date Instrument Type
Ex-Date Split Ratio Record Date
Ex-Date Purpose Notes
Ex-Date Bonus Ratio Record Date

FAQs

The latest market price of Zenith Drugs Ltd. on NSE was Rs. 78.15 as of today.

The opening share price of Zenith Drugs Ltd. was Rs. 75.80 as of today.

The 52-week high share price of Zenith Drugs Ltd. was Rs. 114.50.

The 52 week low share price of Zenith Drugs Ltd. was Rs. 52.80.

Zenith Drugs Ltd. has a market cap of Rs. 134.00 crore as of today. Please refer to the Fundamentals section for further details.

The PE ratio of Zenith Drugs Ltd. is 0.00. Please refer to the Fundamentals section for further details.

The operating revenue for Zenith Drugs Ltd. in the last FY was Rs.  0.00 crore. Please refer to the Financials section for further details.

The Net Profit for Zenith Drugs Ltd. in the last FY was Rs. 0.00 crore. Please refer to the Financials section for further details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please find Corporate actions section for more details.

Please find Corporate actions section for more details.

Please find Corporate actions section for more details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Zenith Drugs Ltd..

Close

Let's Open Free Demat Account